Viewing Study NCT06569797



Ignite Creation Date: 2024-10-26 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06569797
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-07

Brief Title: Effect of Oligosaccharides and Optimizing Multiple Nutrients to Infant Formula on Growth and Development of Infants
Sponsor: None
Organization: None

Study Overview

Official Title: The Effect of Adding Milk Oligosaccharides and Optimizing Multiple Nutrients to Infant Formula on the Growth and Development of Infants Aged 0-1 Years a Multicenter Double-blind Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The research objective is to compare the effects of infant formula supplemented with milk oligosaccharides and optimized with multiple nutrients on the immune function of infants under 1 year old with conventional infant formula and to compare the effects of different infant formulas on infant intestinal health immune function growth and development cognitive development and tolerance with those of breastfed infants
Detailed Description: In this clinical trial the effects of adding oligosaccharides to breast milk and optimizing multiple nutrients in infant formula conventional infant formula and breast milk on the growth and development of infants under 1 year old were evaluated by comparing the intestinal indicators 16s rRNA SCFAs inflammatory indicators nutritional indicators immune indicators growth and development indicators bone development indicators tolerance indicators cognitive development adverse events and serious adverse events of 80 experimental groups 80 control groups and 80 breastfeeding groups

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None